Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis

Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031

Published Year:
SKU:BHM1212SA

$5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Market Report Coverage

Next-Generation Oncology Devices and Solutions Market
Forecast Period: 2022-2031
CAGR During Forecast Period: 6.41%

Next-Generation Oncology Devices and Solutions Market

Base Year

2021

Market Size in 2021

$3,268.2 Million

Forecast Period

2022-2031

Value Projection and Estimation by 2031

$5,971.3 Million

CAGR During Forecast Period

6.41%

Number of Tables

20

Number of Pages

177

Number of Figures

151

 

How Can This Report Add Value to an Organization?

The study provides the reader a detailed understanding of the different devices and solutions by clinical application.

Type: The ‘type’ segment helps the reader understand the different types of next-generation oncology devices and solutions available in the market. Moreover, the study provides the reader a detailed understanding of the different devices and solutions by clinical application (lung cancer, prostate cancer, breast cancer, and others). Furthermore, the study also covers different segments of type ((Device (Technology (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy, and Others), Application (Diagnosis and Treatment and Monitoring)), Software (Application (Diagnosis and Treatment and Monitoring))).

Growth/Marketing Strategy: The global next-generation oncology devices and solutions market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market. For instance, In April 2022, Brainlab's patient monitoring and positioning system secured CE mark. In May 2022, Varian Medical Systems (a subsidiary of Siemens AG) and HP entered into a partnership with Adaptiiv to support cancer treatment.

Industry & Technology Overview

The market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031.

Global Next-Generation Oncology Devices and Solutions Market Industry Overview

The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031. The market is driven by factors such as the increasing prevalence of oncology, increasing demand for software solutions in oncology, emerging technologies in oncology testing and treatment, and rising preference for minimally invasive techniques of diagnosis and treatment.

Market Lifecycle Stage

The next-generation oncology devices and solutions market is still in the development phase. Increased research and development activities are underway to develop more products.

The opportunity for growth of the next-generation oncology devices and solutions market lies in the increasing demand for home-based cancer testing and the growing demand for targeted therapy.

Next-Generation Oncology Devices and Solutions Market

Impact of COVID-19

The pandemic led to the deferral of cancer diagnosis by patients owing to factors such as the risk of virus transmission and higher priority given to the management of COVID-19 cases. Before the COVID-19 pandemic, cancer screening and treatment were majorly undertaken in hospitals and clinical facilities. The emphasis on home-based oncology care was still in its nascent stage. The pandemic led to a deferral of screening and treatment for various types of cancers. Owing to factors such as travel restrictions and risk of transmission of the virus, there was an increased demand for home-based care during the pandemic. While teleconsultations witnessed a drastic increase throughout the healthcare industry, there was also increased demand for home-based tests for screening and monitoring cancerous disorders. Software solutions for oncology also witnessed higher demand as a result of the pandemic.

As the recovery phase of the COVID-19 pandemic begins, cancer diagnosis and treatment procedures are expected to normalize. The shift in preference to home-based care is expected to continue even after the pandemic subsides.

Market Segmentation:

Segmentation 1: by Clinical Application
•    Lung Cancer
•    Prostate Cancer
•    Breast Cancer
•    Others

The global next-generation oncology devices and solutions market in the clinical application segment is expected to be dominated by the breast cancer and the others segment.

Segmentation 2: by Type 
•    Devices
     By Technology
        o    High-Intensity Focused Ultrasound
        o    Advanced Forms of Radiation Therapy
        o    Others
     By Application
        o    Diagnosis
        o    Treatment and Monitoring
•    Software
     By Application
        o    Diagnosis 
        o    Treatment and Monitoring

Segmentation 3: by End User 
•    Hospitals
•    Diagnostic Imaging Centers
•    Others

The global next-generation oncology devices and solutions in the end user segment is dominated by the hospital segment.

Segmentation 4: by Region

•    North America - U.S., Canada
•    Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
•    Asia-Pacific - Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific 
•    Rest-of-the-World - Kingdom of Saudi Arabia (K.S.A.), Brazil, U.A.E., Mexico, and Rest-of-Rest-of-the-World

Recent Developments in the Global Next-Generation Oncology Devices and Solutions Market

•    In May 2022, Varian Medical Systems and HP partnered with Adaptiiv for supporting cancer treatment.
•    In April 2022, Brainlab's patient monitoring and positioning system secured CE Mark.
•    In April 2022, GE Healthcare and Elekta entered into partnership to expand the access of precision radiation therapy solutions.
•    In March 2022, Paige AI Inc. launched its latest product, Paige Breast Lymph Node.
•    In March 2022, Paige AI Inc. launched its pathology AI for detecting breast cancer metastases in lymph nodes.
•    In February 2022, Paige and Mindpeak announced partnership to expand the access of industry – leading AI software for breast cancer.
•    In January 2022, Oulu University Hospital partnered with Varian and Siemens Healthcare to build a comprehensive ecosystem addressing cancer treatment pathway.
•    In December 2021, UofL Health entered into collaboration with Paige AI Inc. to deploy cancer detection software suite of Paige AI Inc.
•    In November 2021, Hologic received CE mark for Genius cervical cancer software.

Demand – Drivers and Limitations

Following are the drivers for the next-generation oncology devices and solutions market:

•    Increasing Prevalence of Oncology and a Growing Geriatric Population
•    Increase in Demand for Software Solutions in Oncology
•    Emerging Technologies in Oncology Testing and Treatment
•    Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment

The market is expected to face some limitations too due to the following challenges:

•    Side Effects and Risks Associated with Cancer Treatment
•    Dearth of Well-Trained and Skilled Professionals in Oncology

Analyst Thoughts

According to Swati Sood, Principal Analyst, BIS Research, “The global next-generation oncology devices and solutions is expected to witness significant growth in emerging economies due to factors such as the increasing prevalence of oncology, upsurge in emerging technologies and software of oncology solutions as well as rising adoption of technologies across countries such as Japan, South Korea, India, and Brazil.”

Table of Contents

Download this TOC

Request a Sample

1.1    Global Market Outlook
         1.1.1    Product Definition
         1.1.2    Inclusion and Exclusion Criteria
         1.1.3    Key Findings
         1.1.4    Assumptions and Limitations
         1.1.5    Global Market Scenario
                     1.1.5.1    Realistic Growth Scenario
                     1.1.5.2    Optimistic Growth Scenario
                     1.1.5.3    Pessimistic/Conservative Growth Scenario
1.2    Industry Outlook
         1.2.1    Key Trends
                     1.2.1.1    Emerging Use of Wearables
                     1.2.1.2    Growing Demand for Point-of-Care Testing (POCT) in Oncology
                     1.2.1.3    Growing Popularity of Smartphone-Based Diagnostics
                     1.2.1.4    Growing Demand for Minimally Invasive Methods of Cancer Diagnosis
                     1.2.1.5    Rising Number of Partnerships and Regulatory Milestones
         1.2.2    Opportunity Assessment
                     1.2.2.1    Short-Term Potential
                     1.2.2.2    Long-Term Potential
         1.2.3    Patent Analysis
                     1.2.3.1    Awaited Technological Developments
                     1.2.3.2    Patent Filing Trend (by Country)
                     1.2.3.3    Patent Filing Trend (by Year)
         1.2.4    Product Benchmarking
         1.2.5    End-User Perceptions
         1.2.6    Case Studies
                     1.2.6.1    Stereotactic Body Radiation Therapy (SBRT) using TrueBeam for Inoperable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
                     1.2.6.2    Breast Cancer Treatment Using Halcyon
1.3    Impact of COVID-19 on the Next-Generation Oncology Devices and Solutions Market
         1.3.1    Impact on Adoption of Oncology Solutions
         1.3.2    Impact on Market Size
                     1.3.2.1    Pre-COVID-19 Phase
                     1.3.2.2    During COVID-19 Phase
                     1.3.2.3    Post-COVID-19 Phase
         1.3.3    Market Entry Barriers and Opportunities
1.4    Business Dynamics
         1.4.1    Impact Analysis
         1.4.2    Business Drivers
                     1.4.2.1    Increasing Prevalence of Oncology and a Growing Geriatric Population
                     1.4.2.2    Increase in Demand for Software Solutions in Oncology
                     1.4.2.3    Emerging Technologies in Oncology Testing and Treatment
                     1.4.2.4    Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment
         1.4.3    Business Restraints
                     1.4.3.1    Side Effects and Risks Associated with Cancer Treatment
                     1.4.3.2    Dearth of Well-Trained and Skilled Professionals in Oncology
         1.4.4    Business Opportunities
                     1.4.4.1    Increasing Demand for Home-Based Cancer Testing
                     1.4.4.2    Growing Demand for Targeted Therapy

2.1    Opportunity Assessment
2.2    Growth-Share Matrix
2.3    Lung Cancer
2.4    Prostate Cancer
2.5    Breast Cancer
2.6    Others

3.1    Opportunity Assessment
3.2    Growth-Share Matrix
3.3    Hospitals
3.4    Diagnostic Imaging Centers
3.5    Others (Ambulatory Surgical Centers, Cancer Care Centers, and Government Institutions)

4.1    Opportunity Assessment
4.2    Growth-Share Matrix
4.3    Devices
         4.3.1    By Technology
                     4.3.1.1    High-Intensity Focused Ultrasound
                     4.3.1.2    Advanced Forms of Radiation Therapy
                     4.3.1.3    Others
         4.3.2    By Application
                     4.3.2.1    Diagnosis
                     4.3.2.2    Treatment and Monitoring
4.4    Software
         4.4.1    By Application
                     4.4.1.1    Diagnosis
                     4.4.1.2    Treatment and Monitoring

5.1    North America Next-Generation Oncology Devices and Solutions Market
         5.1.1    Key Findings and Opportunity Assessment
         5.1.2    Regulatory Framework
         5.1.3    Key Players in North America
         5.1.4    Market Dynamics
                     5.1.4.1    Impact Analysis
         5.1.5    Sizing and Forecast Analysis
                     5.1.5.1    North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                     5.1.5.2    North America Next-Generation Oncology Devices and Solutions Market (by End User)
                     5.1.5.3    North America Next-Generation Oncology Devices and Solutions Market (by Type)
                                    5.1.5.3.1    North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
                                    5.1.5.3.2    North America Next-Generation Oncology Devices and Solutions Market, Device (by Application)
                                    5.1.5.3.3    North America Next-Generation Oncology Devices and Solutions Market, Software (by Application)
                     5.1.5.4    North America Next-Generation Oncology Devices and Solutions Market (by Country)
                                    5.1.5.4.1    U.S.
                                                      5.1.5.4.1.1    Market Dynamics
                                                      5.1.5.4.1.2    Sizing and Forecast Analysis
                                                      5.1.5.4.1.3    U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                      5.1.5.4.1.4    U.S. Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.1.5.4.2    Canada
                                                      5.1.5.4.2.1    Market Dynamics
                                                      5.1.5.4.2.2    Sizing and Forecast Analysis
                                                      5.1.5.4.2.3    Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                      5.1.5.4.2.4    Canada Next-Generation Oncology Devices and Solutions Market (by End User)
5.2    Europe Next-Generation Oncology Devices and Solutions Market
         5.2.1    Key Findings and Opportunity Assessment
         5.2.2    Regulatory Framework
         5.2.3    Key Players in Europe
         5.2.4    Market Dynamics
                     5.2.4.1    Impact Analysis
         5.2.5    Sizing and Forecast Analysis
                     5.2.5.1    Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                     5.2.5.2    Europe Next-Generation Oncology Devices and Solutions Market (by End User)
                     5.2.5.3    Europe Next-Generation Oncology Devices and Solutions Market (by Type)
                                    5.2.5.3.1    Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
                                    5.2.5.3.2    Europe Next-Generation Oncology Devices and Solutions Market, Device (by Application)
                                    5.2.5.3.3    Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application)
                     5.2.5.4    Europe Next-Generation Oncology Devices and Solutions Market (by Country)
                                    5.2.5.4.1    Germany
                                                      5.2.5.4.1.1    Market Dynamics
                                                      5.2.5.4.1.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.1.2.1    Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.1.2.2    Germany Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.2.5.4.2    U.K.
                                                      5.2.5.4.2.1    Market Dynamics
                                                      5.2.5.4.2.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.2.2.1    U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.2.2.2    U.K. Next-Generation Oncology Devices and Solutions Market (by End User)    
                                    5.2.5.4.3    France
                                                      5.2.5.4.3.1    Market Dynamics
                                                      5.2.5.4.3.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.3.2.1    France Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.3.2.2    France Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.2.5.4.4    Italy
                                                      5.2.5.4.4.1    Market Dynamics
                                                      5.2.5.4.4.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.4.2.1    Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.4.2.2    Italy Next-Generation Oncology Devices and Solutions Market (by End User)    
                                    5.2.5.4.5    Spain
                                                      5.2.5.4.5.1    Market Dynamics
                                                      5.2.5.4.5.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.5.2.1    Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.5.2.2    Spain Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.2.5.4.6    Rest-of-Europe
                                                      5.2.5.4.6.1    Market Dynamics
                                                      5.2.5.4.6.2    Sizing and Forecast Analysis
                                                                           5.2.5.4.6.2.1    Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.2.5.4.6.2.2    Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User)
5.3    Asia-Pacific Next-Generation Oncology Devices and Solutions Market    
         5.3.1    Key Findings and Opportunity Assessment
         5.3.2    Regulatory Framework
         5.3.3    Key Players in Asia-Pacific
         5.3.4    Market Dynamics
                     5.3.4.1    Impact Analysis
         5.3.5    Sizing and Forecast Analysis
                     5.3.5.1    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                     5.3.5.2    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User)
                     5.3.5.3    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type)
                                   5.3.5.3.1    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
                                   5.3.5.3.2    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Device (by Application)
                                   5.3.5.3.3    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application)
                     5.3.5.4    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country)
                                    5.3.5.4.1    Japan
                                                      5.3.5.4.1.1    Market Dynamics
                                                      5.3.5.4.1.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.1.2.1    Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.1.2.2    Japan Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.3.5.4.2    China
                                                      5.3.5.4.2.1    Market Dynamics
                                                      5.3.5.4.2.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.2.2.1    China Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.2.2.2    China Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.3.5.4.3    Australia
                                                      5.3.5.4.3.1    Market Dynamics
                                                      5.3.5.4.3.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.3.2.1    Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.3.2.2    Australia Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.3.5.4.4    India
                                                      5.3.5.4.4.1    Market Dynamics
                                                      5.3.5.4.4.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.4.2.1    India Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.4.2.2    India Next-Generation Oncology Devices and Solutions Market (by End User)    
                                    5.3.5.4.5    South Korea
                                                      5.3.5.4.5.1    Market Dynamics
                                                      5.3.5.4.5.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.5.2.1    South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.5.2.2    South Korea Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.3.5.4.6    Rest-of-Asia-Pacific
                                                      5.3.5.4.6.1    Market Dynamics
                                                      5.3.5.4.6.2    Sizing and Forecast Analysis
                                                                           5.3.5.4.6.2.1    Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.3.5.4.6.2.2    Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User)
5.4    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market
         5.4.1    Key Findings and Opportunity Assessment
         5.4.2    Regulatory Framework
         5.4.3    Key Players in Rest-of-the-World
         5.4.4    Market Dynamics
                     5.4.4.1    Impact Analysis
         5.4.5    Sizing and Forecast Analysis
                     5.4.5.1    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                     5.4.5.2    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User)
                     5.4.5.3    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type)
                                    5.4.5.3.1    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology)
                                    5.4.5.3.2    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Device (by Application)
                                    5.4.5.3.3    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application)
                     5.4.5.4    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country)
                                    5.4.5.4.1    Kingdom of Saudi Arabia (K.S.A.)
                                                      5.4.5.4.1.1    Market Dynamics
                                                      5.4.5.4.1.2    Sizing and Forecast Analysis
                                                                           5.4.5.4.1.2.1    K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.4.5.4.1.2.2    K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.4.5.4.2    Brazil
                                                      5.4.5.4.2.1    Market Dynamics
                                                      5.4.5.4.2.2    Sizing and Forecast Analysis
                                                                           5.4.5.4.2.2.1    Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.4.5.4.2.2.2    Brazil Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.4.5.4.3    U.A.E.
                                                      5.4.5.4.3.1    Market Dynamics
                                                      5.4.5.4.3.2    Sizing and Forecast Analysis
                                                                           5.4.5.4.3.2.1    U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.4.5.4.3.2.2    U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.4.5.4.4    Mexico
                                                      5.4.5.4.4.1    Market Dynamics
                                                      5.4.5.4.4.2    Sizing and Forecast Analysis
                                                                           5.4.5.4.4.2.1    Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.4.5.4.4.2.2    Mexico Next-Generation Oncology Devices and Solutions Market (by End User)
                                    5.4.5.4.5    Rest-of-Rest-of-the-World
                                                      5.4.5.4.5.1    Market Dynamics
                                                      5.4.5.4.5.2    Sizing and Forecast Analysis
                                                                           5.4.5.4.5.2.1    Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
                                                                           5.4.5.4.5.2.2    Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User)

6.1    Competitive Landscape
         6.1.1    Key Strategies and Developments
                     6.1.1.1    Regulatory and Legal Activities
                    6.1.1.2    Partnerships, Alliances, and Business Expansions
                    6.1.1.3    New Offerings
                    6.1.1.4    Mergers and Acquisitions
                    6.1.1.5    Funding Activities
6.2    Market Share Analysis

Table 1:    Global Next-Generation Oncology Devices and Solutions Market, Quarterly Key Developments Analysis, January 2018-April 2022
Table 2:    Global Next-Generation Oncology Devices and Solutions Market, Key Entry Barriers and Possible Solutions
Table 3:    Key Software Solutions in Oncology
Table 4:    Key Technologies and Products in Oncology for Diagnosis and Treatment
Table 5:    Key Players Offering HIFU Devices for Cancer
Table 6:    Key Products Based on IGRT and IMRT Technology
Table 7:    Key Players Offering Next-Generation Oncology Devices for Diagnosis
Table 8:    Key Players Offering Next-Generation Oncology Devices for Treatment and Monitoring of Cancer
Table 9:    Key Players Offering Next-Generation Oncology Software for Diagnosis
Table 10:    Key Players Offering Next-Generation Oncology Software for Treatment and Monitoring
Table 11:    North America Next-Generation Oncology Devices and Solutions Market Regulatory Framework
Table 12:    U.S. Next-Generation Oncology Devices and Solutions Market, Key Players and Product Offering
Table 13:    North America Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
Table 14:    Key Players in France Next-Generation Oncology Devices and Software Market
Table 15:    Key Players in Rest-of-Europe Next-Generation Oncology Devices and Solutions Market
Table 16:    Europe Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
Table 17:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market Regulatory Framework
Table 18:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
Table 19:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Regulatory Framework
Table 20:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis

Figure 1:    Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
Figure 2:    Global Next-Generation Oncology Devices and Solutions Market (by Region), $Million, 2021 and 2031
Figure 3:    Global Next-Generation Oncology Devices and Solutions Market Segmentation
Figure 4:    Global Next-Generation Oncology Devices and Solutions Market Research Methodology
Figure 5:    Primary Research
Figure 6:    Secondary Research
Figure 7:    Data Triangulation
Figure 8:    Global Next-Generation Oncology Devices and Solutions Market Research Process
Figure 9:    Assumptions and Limitations
Figure 10:    Global Next-Generation Oncology Devices and Solutions Market, Potential Forecast Scenarios
Figure 11:    Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
Figure 12:    Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
Figure 13:    Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2020-2031
Figure 14:    Global Next-Generation Oncology Devices and Solutions Market Key Trends, Short-Term Potential
Figure 15:    Global Next-Generation Oncology Devices and Solutions Market Key Trends, Long-Term Potential
Figure 16:    Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Country), January 2018-April 2022
Figure 17:    Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Year), January 2018–April 2022
Figure 18:    Key Players’ Product Offerings (by Type)
Figure 19:    Global Next-Generation Oncology Devices and Solutions Market, Pre-COVID-19 Phase, $Million, 2020-2031
Figure 20:    Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
Figure 21:    Global Number of New Cases for All Cancers, 2020-2040
Figure 22:    Global Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
Figure 23:    Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Clinical Application), $Million, 2021-2031
Figure 24:    Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Clinical Application), 2021-2031
Figure 25:    Global Next-Generation Oncology Devices and Solutions Market (Lung Cancer), $Million, 2020-2031
Figure 26:    Global Next-Generation Oncology Devices and Solutions Market (Prostate Cancer), $Million, 2020-2031
Figure 27:    Global Next-Generation Oncology Devices and Solutions Market (Breast Cancer), $Million, 2020-2031
Figure 28:    Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 29:    Global Next-Generation Oncology Devices and Solutions Market (by End User)
Figure 30:    Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by End User), $Million, 2021-2031
Figure 31:    Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by End User), 2021-2031
Figure 32:    Global Next-Generation Oncology Devices and Solutions Market (Hospitals), $Million, 2020-2031
Figure 33:    Global Next-Generation Oncology Devices and Solutions Market (Diagnostic Imaging Centers), $Million, 2020-2031
Figure 34:    Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 35:    Global Next-Generation Oncology Devices and Solutions Market (by Type)
Figure 36:    Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Type), $Million, 2021-2031
Figure 37:    Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Type), 2021-2031
Figure 38:    Global Next-Generation Oncology Devices and Solutions Market (High-Intensity Focused Ultrasound), $Million, 2020-2031
Figure 39:    Global Next-Generation Oncology Devices and Solutions Market (Advanced Forms of Radiation Therapy), $Million, 2020-2031
Figure 40:    Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 41:    Global Next-Generation Oncology Devices and Solutions Market, Devices (Diagnosis), $Million, 2020-2031
Figure 42:    Global Next-Generation Oncology Devices and Solutions Market, Devices (Treatment and Monitoring), $Million, 2020-2031
Figure 43:    Global Next-Generation Oncology Devices and Solutions Market, Software (Diagnosis), $Million, 2020-2031
Figure 44:    Global Next-Generation Oncology Devices and Solutions Market, Software (Treatment and Monitoring), $Million, 2020-2031
Figure 45:    Global Next-Generation Oncology Devices and Solutions Market Share (by Region), 2021-2031
Figure 46:    North America Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 47:    Prevalence of Different Cancer in North America, 2010, 2015, and 2019
Figure 48:    Number of New Cases for All Cancers in North America, 2020-2040
Figure 49:    North America Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 50:    North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 51:    North America Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 52:    North America Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
Figure 53:    North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
Figure 54:    North America Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
Figure 55:    North America Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
Figure 56:    North America Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
Figure 57:    U.S. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 58:    U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 59:    U.S. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 60:    Canada Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 61:    Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 62:    Canada Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 63:    Europe Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 64:    Number of New Cases for All Cancers in Europe, 2020-2040
Figure 65:    Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 66:    Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 67:    Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 68:    Europe Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
Figure 69:    Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
Figure 70:    Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
Figure 71:    Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
Figure 72:    Europe Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
Figure 73:    Germany Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 74:    Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 75:    Germany Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 76:    U.K. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 77:    U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 78:    U.K. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 79:    France Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 80:    France Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 81:    France Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 82:    Italy Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 83:    Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 84:    Italy Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 85:    Spain Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 86:    Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 87:    Spain Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 88:    Rest-of-Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 89:    Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 90:    Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 91:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 92:    Prevalence of Different Cancer in Asia-Pacific, 2010, 2015, and 2019
Figure 93:    Number of New Cases for All Cancers in Asia-Pacific, 2020-2040
Figure 94:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 95:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 96:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 97:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
Figure 98:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
Figure 99:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
Figure 100:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
Figure 101:    Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
Figure 102:    Japan Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 103:    Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 104:    Japan Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 105:    China Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 106:    China Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 107:    China Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 108:    Australia Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 109:    Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 110:    Australia Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 111:    India Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 112:    India Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 113:    India Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 114:    South Korea Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 115:    South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 116:    South Korea Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 117:    Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 118:    Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 119:    Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 120:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 121:    Number of New Cases for All Cancers in Africa and Latin America, 2020-2040
Figure 122:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 123:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 124:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 125:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
Figure 126:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031
Figure 127:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031
Figure 128:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031
Figure 129:    Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031
Figure 130:    K.S.A. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 131:    K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 132:    K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 133:    Brazil Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 134:    Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 135:    Brazil Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 136:    U.A.E. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 137:    U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 138:    U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 139:    Mexico Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 140:    Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 141:    Mexico Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 142:    Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 143:    Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031
Figure 144:    Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031
Figure 145:    Share of Key Developments and Strategies, January 2018-April 2022
Figure 146:    Regulatory and Legal Activities (by Company), January 2018-April 2022
Figure 147:    Partnerships, Alliances, and Business Expansions (by Company), January 2018-April 2022
Figure 148:    New Offerings (by Company), January 2018-April 2022
Figure 149:    Mergers and Acquisitions (by Company), January 2018-April 2022
Figure 150:    Funding Activities (by Company), January 2018-April 2022
Figure 151:    Global Next-Generation Oncology Devices and Solutions Market, Company Revenue Share Analysis, $Million, 2021

Market Report Coverage

Next-Generation Oncology Devices and Solutions Market

Base Year

2021

Market Size in 2021

$3,268.2 Million

Forecast Period

2022-2031

Value Projection and Estimation by 2031

$5,971.3 Million

CAGR During Forecast Period

6.41%

Number of Tables

20

Number of Pages

177

Number of Figures

151

 

How Can This Report Add Value to an Organization?

Type: The ‘type’ segment helps the reader understand the different types of next-generation oncology devices and solutions available in the market. Moreover, the study provides the reader a detailed understanding of the different devices and solutions by clinical application (lung cancer, prostate cancer, breast cancer, and others). Furthermore, the study also covers different segments of type ((Device (Technology (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy, and Others), Application (Diagnosis and Treatment and Monitoring)), Software (Application (Diagnosis and Treatment and Monitoring))).

Growth/Marketing Strategy: The global next-generation oncology devices and solutions market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market. For instance, In April 2022, Brainlab's patient monitoring and positioning system secured CE mark. In May 2022, Varian Medical Systems (a subsidiary of Siemens AG) and HP entered into a partnership with Adaptiiv to support cancer treatment.

Industry & Technology Overview

Global Next-Generation Oncology Devices and Solutions Market Industry Overview

The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031. The market is driven by factors such as the increasing prevalence of oncology, increasing demand for software solutions in oncology, emerging technologies in oncology testing and treatment, and rising preference for minimally invasive techniques of diagnosis and treatment.

Market Lifecycle Stage

The next-generation oncology devices and solutions market is still in the development phase. Increased research and development activities are underway to develop more products.

The opportunity for growth of the next-generation oncology devices and solutions market lies in the increasing demand for home-based cancer testing and the growing demand for targeted therapy.

Next-Generation Oncology Devices and Solutions Market

Impact of COVID-19

The pandemic led to the deferral of cancer diagnosis by patients owing to factors such as the risk of virus transmission and higher priority given to the management of COVID-19 cases. Before the COVID-19 pandemic, cancer screening and treatment were majorly undertaken in hospitals and clinical facilities. The emphasis on home-based oncology care was still in its nascent stage. The pandemic led to a deferral of screening and treatment for various types of cancers. Owing to factors such as travel restrictions and risk of transmission of the virus, there was an increased demand for home-based care during the pandemic. While teleconsultations witnessed a drastic increase throughout the healthcare industry, there was also increased demand for home-based tests for screening and monitoring cancerous disorders. Software solutions for oncology also witnessed higher demand as a result of the pandemic.

As the recovery phase of the COVID-19 pandemic begins, cancer diagnosis and treatment procedures are expected to normalize. The shift in preference to home-based care is expected to continue even after the pandemic subsides.

Market Segmentation:

Segmentation 1: by Clinical Application
•    Lung Cancer
•    Prostate Cancer
•    Breast Cancer
•    Others

The global next-generation oncology devices and solutions market in the clinical application segment is expected to be dominated by the breast cancer and the others segment.

Segmentation 2: by Type 
•    Devices
     By Technology
        o    High-Intensity Focused Ultrasound
        o    Advanced Forms of Radiation Therapy
        o    Others
     By Application
        o    Diagnosis
        o    Treatment and Monitoring
•    Software
     By Application
        o    Diagnosis 
        o    Treatment and Monitoring

Segmentation 3: by End User 
•    Hospitals
•    Diagnostic Imaging Centers
•    Others

The global next-generation oncology devices and solutions in the end user segment is dominated by the hospital segment.

Segmentation 4: by Region

•    North America - U.S., Canada
•    Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
•    Asia-Pacific - Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific 
•    Rest-of-the-World - Kingdom of Saudi Arabia (K.S.A.), Brazil, U.A.E., Mexico, and Rest-of-Rest-of-the-World

Recent Developments in the Global Next-Generation Oncology Devices and Solutions Market

•    In May 2022, Varian Medical Systems and HP partnered with Adaptiiv for supporting cancer treatment.
•    In April 2022, Brainlab's patient monitoring and positioning system secured CE Mark.
•    In April 2022, GE Healthcare and Elekta entered into partnership to expand the access of precision radiation therapy solutions.
•    In March 2022, Paige AI Inc. launched its latest product, Paige Breast Lymph Node.
•    In March 2022, Paige AI Inc. launched its pathology AI for detecting breast cancer metastases in lymph nodes.
•    In February 2022, Paige and Mindpeak announced partnership to expand the access of industry – leading AI software for breast cancer.
•    In January 2022, Oulu University Hospital partnered with Varian and Siemens Healthcare to build a comprehensive ecosystem addressing cancer treatment pathway.
•    In December 2021, UofL Health entered into collaboration with Paige AI Inc. to deploy cancer detection software suite of Paige AI Inc.
•    In November 2021, Hologic received CE mark for Genius cervical cancer software.

Demand – Drivers and Limitations

Following are the drivers for the next-generation oncology devices and solutions market:

•    Increasing Prevalence of Oncology and a Growing Geriatric Population
•    Increase in Demand for Software Solutions in Oncology
•    Emerging Technologies in Oncology Testing and Treatment
•    Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment

The market is expected to face some limitations too due to the following challenges:

•    Side Effects and Risks Associated with Cancer Treatment
•    Dearth of Well-Trained and Skilled Professionals in Oncology

Analyst Thoughts

According to Swati Sood, Principal Analyst, BIS Research, “The global next-generation oncology devices and solutions is expected to witness significant growth in emerging economies due to factors such as the increasing prevalence of oncology, upsurge in emerging technologies and software of oncology solutions as well as rising adoption of technologies across countries such as Japan, South Korea, India, and Brazil.”

You may also like

Published Year:2021

Interventional Oncology Devices Market - A Global and Regional Analysis: Focus on Cancer Type, Produ

The global interventional oncology devices market was valued at $2,429.2 million in 2020 and...

Next-Generation Oncology Devices and Solutions Market - A Global and Regional Analysis

Focus on Clinical Application, End User, Type, and Region - Analysis and Forecast, 2022-2031